Skip to main content
. 2018 Feb 21;24(7):819–832. doi: 10.3748/wjg.v24.i7.819

Figure 6.

Figure 6

Effect of metformin on AMPK, Akt/mTOR, and ERK signaling in hepatic stellate cells. A and B: HSCs were pretreated with metformin (1, 2, 5 and 10 mmol/L) for 2 h and then incubated with PDGF-BB (10 ng/mL) for 24 h or CoCl2 (150 μmol/L) for 12 h. AMPK, Akt/mTOR, and ERK signaling pathways were assessed by Western blot analysis; C and D: The results were quantified. aP < 0.05 vs the control group, cP < 0.05 and dP < 0.01 vs the PDGF-BB or CoCl2 only groups. HSCs: Hepatic stellate cells.